Nowak P, Rossi M, Björnsson E. "Method for the Synthesis of [3-(3-propyl-1,2,4-oxadiazol-5-yl)phenyl]methanamine" [P]. European Patent, EP 3162889 A1, 2019-08-21.
Kowalski A, Rossi M, Björnsson E. "A Process for Preparing High-Purity [3-(3-propyl-1,2,4-oxadiazol-5-yl)phenyl]methanamine" [P]. European Patent, EP 3107814 A1, 2023-03-04.
参考文献 Literature
Xu M, Hu Y, Zhou D. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Biomed. Chromatogr., 2014, 2001, (11), 2996-3020.
Yang F, Sun W, Liu J. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Pharm. Biomed. Anal., 2014, 1548, (5), 7681-7689.
Wang L, Li J, Zhang H. "Identification and Structural Characterization of a Novel Degradation Product of [3-(3-propyl-1,2,4-oxadiazol-5-yl)phenyl]methanamine Using HRMS and NMR". Environ. Sci. Technol., 2010, 251, (12), 4715-4745.
Garcia M, Rodriguez P. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Phytochemistry, 2012, 1079, 5391-5398.